These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy? Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069 [TBL] [Abstract][Full Text] [Related]
35. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease. Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674 [TBL] [Abstract][Full Text] [Related]
36. Asymmetric Graves' Orbitopathy. Panagiotou G; Perros P Front Endocrinol (Lausanne); 2020; 11():611845. PubMed ID: 33391188 [TBL] [Abstract][Full Text] [Related]